A novel mixed polymeric micelle for co-delivery of paclitaxel and retinoic acid and overcoming multidrug resistance: synthesis, characterization, cytotoxicity, and pharmacokinetic evaluation

References

• Sledge GW, Neuberg D, Bernardo P, et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol. 2003;21:588–592.
   PubMed Web of Science ®Google Scholar
• CarrickParker SS, Thornton C, Ghersi E, et al. Single agent versus combination chemotherapy for metastatic breast cancer. The Cochrane Library. 2009;(2):CD003372.
   Google Scholar
• Bang Y-J, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–697.
   PubMed Web of Science ®Google Scholar
• Zhu W-Y, Jones CS, Kiss A, et al. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res. 1997;234:293–299.
   PubMed Web of Science ®Google Scholar
• Siddikuzzaman, Guruvayoorappan C, Grace VMB. All trans retinoic acid and cancer. Immunopharmacol Immunotoxicol. 2011;33:241–249.
   PubMed Web of Science ®Google Scholar
• Sano K, Takayama T, Murakami K, et al. Overexpression of retinoic acid receptor α in hepatocellular carcinoma. Clin Cancer Res. 2003;9:3679–3683.
   PubMed Web of Science ®Google Scholar
• Khuri FR, Lee JJ, Lippman SM, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006;98:441–450.
   PubMed Web of Science ®Google Scholar
• Clerici C, Castellani D, Russo G, et al. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. Anticancer Res. 2004;24:1255–1260.
   PubMed Web of Science ®Google Scholar
• Wang R, Xiao H, Song H, et al. Co-delivery of all-trans-retinoic-acid and cisplatin (IV) prodrug based on polymer–drug conjugates for enhanced efficacy and safety. J Mater Chem. 2012;22:25453–25462.
   Web of Science ®Google Scholar
• Yao J, Zhang L, Zhou J, et al. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and paclitaxel based on hyaluronic acid-based multifunctional nanocarrier. Mol Pharmaceut. 2013;10:1080–1091.
   PubMed Web of Science ®Google Scholar
• Sun R, Liu Y, Li S-Y, et al. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells. Biomaterials. 2015;37:405–414.
   PubMed Web of Science ®Google Scholar
• OzpolatLopez-Berestein B, Adamson G, Fu PC, Williams AH. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J Pharm Pharm Sci. 2003;6:292–301.
   PubMed Web of Science ®Google Scholar
• Cho C, Cho K, Park I, et al. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly (L-lactic acid) nanoparticles coated with galactose-carrying polystyrene. J Control Release. 2001;77:7–15.
   PubMed Web of Science ®Google Scholar
• Lim S-J, Kim C-K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharmaceut. 2002;243:135–146.
   PubMed Web of Science ®Google Scholar
• Castro GA, Oréfice RL, Vilela JM, et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul. 2007;24:395–407.
   PubMed Web of Science ®Google Scholar
• Narvekar M, Xue HY, Wong HL. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). Int J Pharmaceut. 2012;436:721–731.
   PubMed Web of Science ®Google Scholar
• Hou L, Yao J, Zhou J, et al. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials. 2012;33:5431–5440.
   PubMed Web of Science ®Google Scholar
• Zhang J, Han J, Zhang X, et al. Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel. Carbohydr Polym. 2015;129:25–34.
   PubMed Web of Science ®Google Scholar
• Pitto-Barry A, Barry NP. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polym Chem. 2014;5:3291–3297.
   Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng S-S. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33:4889–4906.
   PubMed Web of Science ®Google Scholar
• Emami J, Rezazadeh M, Rostami M, et al. Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Indus Pharm. 2015;41:1137–1147.
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials. 2014;35:2391–2400.
   PubMed Web of Science ®Google Scholar
• Xu P, Yin Q, Shen J, et al. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. Int J Pharmaceut. 2013;454:21–30.
   PubMed Web of Science ®Google Scholar
• Gill K, Kaddoumi K, Nazzal AS. Mixed micelles of PEG 2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. Eur J Pharmaceut Sci. 2012;46:64–71.
   PubMed Web of Science ®Google Scholar
• Youk H-J, Lee E, Choi M-K, et al. Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release. 2005;107:43–52.
   PubMed Web of Science ®Google Scholar
• Mi Y, Liu Y, Feng S-S. Formulation of docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS 2k) micelles for targeted and synergistic chemotherapy. Biomaterials. 2011;32:4058–4066.
   PubMed Web of Science ®Google Scholar
• Emami J, Rezazadeh M, Hasanzadeh F, et al. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel. Int J Biol Macromol. 2015;80:29–40.
   PubMed Web of Science ®Google Scholar
• Emami J, Rezazadeh M, Sadeghi H, et al. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box–Behnken design. Pharmaceut Dev Technol. 2017;22:370–382.
   PubMed Web of Science ®Google Scholar
• Mostafavi A, Emami J, Varshosaz J, et al. Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers. Int J Pharmaceut. 2011;409:128–136.
   PubMed Web of Science ®Google Scholar
• EmamiRezazadeh J, Varshosaz MJ. Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity. J Nanomater. 2012;2012:3.
   Google Scholar
• Gao Y, Li LB, Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces. 2008;64:194–199.
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol. 2013;9:1146–1154.
   PubMed Web of Science ®Google Scholar
• Seow WY, Xue JM, Yang Y-Y. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials. 2007;28:1730–1740.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shi Y, Chen Y, et al. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials. 2011;32:2894–2906.
   PubMed Web of Science ®Google Scholar
• Tao Y, Xu J, Chen M, et al. Core cross-linked hyaluronan-styrylpyridinium micelles as a novel carrier for paclitaxel. Carbohydr Polym. 2012;88:118–124.
   Web of Science ®Google Scholar
• Kim SC, Kim DW, Shim YH, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001;72:191–202.
   PubMed Web of Science ®Google Scholar
• Liu J, Li H, Chen D, et al. In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel. Drug Deliv. 2011;18:181–189.
   PubMed Web of Science ®Google Scholar
• Zhang C, Qu G, Sun Y, et al. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials. 2008;29:1233–1241.
   PubMed Web of Science ®Google Scholar